Article Information
History
- November 9, 2022.
Article Versions
- Version 1 (November 2, 2022 - 18:19).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Harrison S France1,*,
- Jeffrey K Aronson2,
- Carl Heneghan2,
- Robin E Ferner3,4,
- Anthony R Cox3,4 and
- Georgia C Richards2
- 1Oxford Medical School, Medical Sciences Divisional Office, University of Oxford, Oxford, OX3 9DU, UK
- 2Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, UK
- 3West Midlands Centre for Adverse Drug Reactions, Birmingham, B18 7QH, UK
- 4College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK
- ↵*Correspondence to: Harrison S France (harrisonsfrance{at}gmail.com), Oxford Medical School, Medical Sciences Divisional Office, University of Oxford, Oxford, OX3 9DU, UK
Posted November 09, 2022.
Preventable deaths involving medicines in England and Wales, 2013-22: a systematic case series of coroners’ reports
